Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comments on the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases.
SEC Working Group for the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases; Pérez de Isla L, Moñux G, Galindo García Á, Revuelta Suero S, Diaz Castro Ó, Barrios V, Arrarte V; Expert Reviewers for the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases; Escobar C, Bravo M, Cosín Sales J, Gómez Doblas JJ, Ruiz Ortiz M, Saltijeral A, Fernández Olmo MR, Toledo Frías P, Beltrán Troncoso P, Campuzano Ruiz R, Alarcón Duque JA, Abeytua M; SEC Guidelines Committee; San Román A, Alfonso F, Evangelista A, Ferreira-González I, Jiménez Navarro M, Marín F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis A, Vázquez García R. SEC Working Group for the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, et al. Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):74-78. doi: 10.1016/j.rec.2017.11.028. Rev Esp Cardiol (Engl Ed). 2018. PMID: 29425610 English, Spanish. No abstract available.
Comments on the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.
SEC Working Group for the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease; Evangelista A, San Román JA, Calvo F, González A, Gómez Doblas JJ, Revilla A, Castillo JA, González C; Expert Reviewers for the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease; Gómez Doblas JJ, López Fernández T, Barreiro M, Oliva MJ, Galian Gay L, Serrador A, Jiménez Quevedo P, Pan M, Arnau Vives MA, López Díaz J, Borrás Pérez X; SEC Guidelines Committee; San Román A, Alfonso F, Evangelista A, Ferreira-González I, Jiménez Navarro M, Marín F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis A, Vázquez García R. SEC Working Group for the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease, et al. Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):67-73. doi: 10.1016/j.rec.2017.11.027. Rev Esp Cardiol (Engl Ed). 2018. PMID: 29425609 English, Spanish. No abstract available.
Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
Sionis A; SEC Working Group for the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure:; Sionis Green A, Manito Lorite N, Bueno H, Coca Payeras A, Díaz Molina B, González Juanatey JR, Ruilope Urioste LM, Zamorano Gómez JL; Expert Reviewers for the 2016 ESC Guidelines for the Treatment of Acute and Chronic Heart Failure:; Almenar Bonet L, Ariza Solé A, Bover Freire R, Lambert Rodríguez JL, López de Sá E, López Fernández S, Martín Asenjo R, Mirabet Pérez S, Pascual Figal D, Segovia Cubero J, Varela Román A; SEC Guidelines Committee:; San Román Calvar JA, Alfonso Manterola F, Arribas Ynsaurriaga F, Evangelista Masip A, Ferreira González I, Jiménez Navarro M, Marin Ortuño F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis Green A, Vázquez García R. Sionis A, et al. Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1119-1125. doi: 10.1016/j.rec.2016.10.015. Rev Esp Cardiol (Engl Ed). 2016. PMID: 27894486 English, Spanish. No abstract available.
Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias.
Pérez de Isla L; SEC Working Group for the 2016 ESC Guidelines for the Management of Dyslipidemias:; Pérez de Isla L, Fernández PLS, Álvarez-Sala Walther L, Barrios Alonso V, Castro Conde A, Galve Basilio E, García Ortiz L, Mata López P; Expert Reviewers for the 2016 ESC Guidelines for the Management of Dyslipidemias:; Alegría Ezquerra E, Cordero Fort A, Cosin Sales J, Escobar Cervantes C, García-Moll Marimón X, José Gómez Doblas J, Marzal Martín D, Murga Eizagaechevarria N, de Pablo Zarzosa C, Miguel Rincón L, Sanchis Forés J; SEC Guidelines Committee:; Alberto San Román Calvar J, Alfonso Manterola F, Arribas Ynsaurriaga F, Evangelista Masip A, Ferreira González I, Jiménez Navarro M, Marín Ortuño F, Pérez de Isla L, Rodríguez Padial L, Luis Sánchez Fernández P, Sionis Green A, Vázquez García R. Pérez de Isla L, et al. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):72-77. doi: 10.1016/j.rec.2017.01.001. Rev Esp Cardiol (Engl Ed). 2017. PMID: 28131410 English, Spanish. No abstract available.
Comments on the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-segment Elevation.
SEC Working Group for the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-segment Elevation:; Alfonso F, Sionis A, Bueno H, Ibáñez B, Sabaté M, Cequier Á, Barrabés J, Sanchis J, Abu-Assi E, Aboal J; Expert Reviewers for the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-segment Elevation; López de Sá E, Martín Asenjo R, Pan M, Ojeda S, Pérez de Prado A, Jiménez Quevedo P, Serrador A, Roldán I, Ferreiro JL, Ruiz Nodar JM, López Sendón JL; SEC Guidelines Committee; San Román A, Alfonso F, Evangelista A, Ferreira-González I, Jiménez Navarro M, Marín F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis A, Vázquez García R. SEC Working Group for the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-segment Elevation:, et al. Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1039-1045. doi: 10.1016/j.rec.2017.11.009. Rev Esp Cardiol (Engl Ed). 2017. PMID: 29198431 English, Spanish. No abstract available.
Comments on the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.
SEC Working Group for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease; Jiménez Navarro M, Avanzas P, Valencia F, Ballesteros S, Ruiz-Nodar JM, Ferreiro JL, Tello Montoliu A, Marín F; Expert Reviewers for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease; Pérez de Prado A, Romero Moreno M, Bravo MS, Ruiz Ortiz M, Escobar C, Roldán I, Vivas Balcones D; SEC Guidelines Committee; San Román A, Alfonso F, Evangelista A, Ferreira-González I, Jiménez Navarro M, Marín F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis A, Vázquez García R. SEC Working Group for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease, et al. Rev Esp Cardiol (Engl Ed). 2018 Jan;71(1):6-12. doi: 10.1016/j.rec.2017.11.019. Rev Esp Cardiol (Engl Ed). 2018. PMID: 29277237 English, Spanish. No abstract available.
Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation.
SEC Working Group for the 2020 ESC Guidelines for the Management of Atrial Fibrillation; Expert Reviewers for the 2020 ESC Guidelines for the Management of Atrial Fibrillation; SEC Guidelines Committee; Working Group for the 2020 ESC guidelines for the management of atrial fibrillation; Expert reviewers for the 2020 ESC guidelines for the management of atrial fibrillation; SEC Guidelines Committee. SEC Working Group for the 2020 ESC Guidelines for the Management of Atrial Fibrillation, et al. Rev Esp Cardiol (Engl Ed). 2021 May;74(5):378-383. doi: 10.1016/j.rec.2020.11.023. Epub 2021 Mar 15. Rev Esp Cardiol (Engl Ed). 2021. PMID: 33736964 English, Spanish. No abstract available.
Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice.
SEC Working Group for the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice and SEC Guidelines Committee. SEC Working Group for the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice and SEC Guidelines Committee. Rev Esp Cardiol (Engl Ed). 2022 May;75(5):364-369. doi: 10.1016/j.rec.2021.10.023. Epub 2022 Feb 11. Rev Esp Cardiol (Engl Ed). 2022. PMID: 35165071 English, Spanish. No abstract available.
Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
SEC Working Group for the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and SEC Guidelines Committee. SEC Working Group for the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and SEC Guidelines Committee. Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):458-465. doi: 10.1016/j.rec.2021.11.023. Epub 2022 Feb 18. Rev Esp Cardiol (Engl Ed). 2022. PMID: 35190290 English, Spanish. No abstract available.
Comments on the 2021 ESC/EACTS guidelines for the management of valvular heart disease.
SEC Working Group for the 2021 ESC/EACTS guidelines for the management of valvular heart disease and SEC Guidelines Committee. SEC Working Group for the 2021 ESC/EACTS guidelines for the management of valvular heart disease and SEC Guidelines Committee. Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):466-471. doi: 10.1016/j.rec.2021.11.024. Epub 2022 Apr 12. Rev Esp Cardiol (Engl Ed). 2022. PMID: 35428581 English, Spanish. No abstract available.
268 results